Literature DB >> 18955527

Microanalysis of beta-lactam antibiotics and vancomycin in plasma for pharmacokinetic studies in neonates.

Maurice J Ahsman1, Enno D Wildschut, Dick Tibboel, Ron A Mathot.   

Abstract

Rational dosing of antibiotics in neonates should be based on pharmacokinetic (PK) parameters assessed in specific populations. PK studies of neonates are hampered by the limited total plasma volume, which restricts the sample volume and sampling frequency. Available drug assay methods require large sample volumes and are labor-intensive or time-consuming. The objective of this study was to develop a rapid ultra-performance liquid chromatographic method with tandem mass spectrometry detection for simultaneous quantification of amoxicillin, meropenem, cefazolin, cefotaxime, deacetylcefotaxime, ceftriaxone, and vancomycin in 50 microl of plasma. Cleanup consisted of protein precipitation with cold acetonitrile (1:4) and solvent evaporation before reversed-phase chromatographic separation and detection using electrospray ionization tandem mass spectrometry. Standard curves were prepared over a large dynamic range with adequate limits of quantitation. Intra- and interrun accuracy and precision were within 100% +/- 15% and 15%, respectively, with acceptable matrix effects. Coefficients of variation for matrix effects and recovery were <10% over six batches of plasma. Stability in plasma and aqueous stocks was generally sufficient, but stability of meropenem and ceftriaxone in extracts could limit autosampler capacity. The instrument run time was approximately 3.50 min per sample. Method applicability was demonstrated with plasma samples from an extracorporeal membrane oxygenation-treated neonate. Different beta-lactam antibiotics can be added to this method with additional ion transitions. Using ultra-performance liquid chromatography mass spectrometry, this method allows simple and reliable quantification of multiple antibiotics in 50 microl of plasma for PK studies of neonates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18955527      PMCID: PMC2612158          DOI: 10.1128/AAC.00636-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  Improving LC-MS sensitivity through increases in chromatographic performance: comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS.

Authors:  Mona I Churchwell; Nathan C Twaddle; Larry R Meeker; Daniel R Doerge
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-07-05       Impact factor: 3.205

2.  Validation and qualification: the fitness for purpose of mass spectrometry-based analytical methods and analytical systems.

Authors:  Maria Careri; Alessandro Mangia
Journal:  Anal Bioanal Chem       Date:  2006-07-25       Impact factor: 4.142

3.  Recent developments in liquid chromatography--impact on qualitative and quantitative performance.

Authors:  Davy Guillarme; Dao T-T Nguyen; Serge Rudaz; Jean-Luc Veuthey
Journal:  J Chromatogr A       Date:  2006-11-28       Impact factor: 4.759

4.  Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates.

Authors:  Joyce Pullen; Leo M L Stolk; Fred H M Nieman; Pieter L J Degraeuwe; Frank H van Tiel; Luc J I Zimmermann
Journal:  Ther Drug Monit       Date:  2006-04       Impact factor: 3.681

5.  Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation.

Authors:  R D Amaker; J T DiPiro; J Bhatia
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

6.  Development and validation of a solid-phase extraction-liquid chromatographic method for determination of amoxicillin in plasma.

Authors:  N Lindegårdh; T Singtoroj; A Annerberg; N J White; N P J Day
Journal:  Ther Drug Monit       Date:  2005-08       Impact factor: 3.681

Review 7.  Criteria supporting the study of drugs in the newborn.

Authors:  Robert M Ward; William E Benitz; Daniel K Benjamin; Lillian Blackmon; George P Giacoia; Mark Hudak; Tamar Lasky; William Rodriguez; Arzu Selen
Journal:  Clin Ther       Date:  2006-09       Impact factor: 3.393

8.  Rapid high-performance liquid chromatographic determination of vancomycin in human plasma.

Authors:  J Luksa; A Marusic
Journal:  J Chromatogr B Biomed Appl       Date:  1995-05-19

9.  Simultaneous quantification of cefotaxime, desacetylcefotaxime, ofloxacine and ciprofloxacine in ocular aqueous humor and in plasma by high-performance liquid chromatography.

Authors:  H J Kraemer; R Gehrke; A Breithaupt; H Breithaupt
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1997-10-24

10.  Quantification of meropenem in plasma and cerebrospinal fluid by micellar electrokinetic capillary chromatography and application in bacterial meningitis patients.

Authors:  Yu-Wei Chou; Yuan-Han Yang; Jin-Hon Chen; Chen-Chun Kuo; Su-Hwei Chen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-06-26       Impact factor: 3.205

View more
  12 in total

1.  Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation.

Authors:  Maurice J Ahsman; Enno D Wildschut; Dick Tibboel; Ron A Mathot
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

2.  Pharmacokinetics and protein binding of cefazolin in morbidly obese patients.

Authors:  Simone van Kralingen; Margot Taks; Jeroen Diepstraten; Ewoudt M van de Garde; Eric P van Dongen; Marinus J Wiezer; Bert van Ramshorst; Bart Vlaminckx; Vera H Deneer; Catherijne A Knibbe
Journal:  Eur J Clin Pharmacol       Date:  2011-04-16       Impact factor: 2.953

Review 3.  Pharmacokinetic studies in infants using minimal-risk study designs.

Authors:  Julie Autmizguine; Daniel K Benjamin; P Brian Smith; Mario Sampson; Philippe Ovetchkine; Michael Cohen-Wolkowiez; Kevin M Watt
Journal:  Curr Clin Pharmacol       Date:  2014

Review 4.  Innovative clinical trial design for pediatric therapeutics.

Authors:  Matthew M Laughon; Daniel K Benjamin; Edmund V Capparelli; Gregory L Kearns; Katherine Berezny; Ian M Paul; Kelly Wade; Jeff Barrett; Phillip Brian Smith; Michael Cohen-Wolkowiez
Journal:  Expert Rev Clin Pharmacol       Date:  2011-09       Impact factor: 5.045

5.  Determination of meropenem in bacterial media by LC-MS/MS.

Authors:  Liusheng Huang; Janus Haagensen; Davide Verotta; Patricia Lizak; Francesca Aweeka; Katherine Yang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-05-14       Impact factor: 3.205

6.  A whole blood microsampling assay for vancomycin: development, validation and application for pediatric clinical study.

Authors:  Ganesh S Moorthy; Kevin J Downes; Christina Vedar; Athena F Zuppa
Journal:  Bioanalysis       Date:  2020-09-18       Impact factor: 2.681

7.  Development and validation of a UHPLC-MS/MS method to measure cefotaxime and metabolite desacetylcefotaxime in blood plasma: a pilot study suitable for capillary microsampling in critically ill children.

Authors:  Yarmarly C Guerra Valero; Tavey Dorofaeff; Jason A Roberts; Jeffrey Lipman; Mark G Coulthard; Louise Sparkes; Steven C Wallis; Suzanne L Parker
Journal:  Anal Bioanal Chem       Date:  2021-05-26       Impact factor: 4.142

8.  Determinants of drug absorption in different ECMO circuits.

Authors:  E D Wildschut; M J Ahsman; K Allegaert; R A A Mathot; D Tibboel
Journal:  Intensive Care Med       Date:  2010-09-23       Impact factor: 17.440

9.  Development of a liquid chromatography-tandem mass spectrometry assay of six antimicrobials in plasma for pharmacokinetic studies in premature infants.

Authors:  Michael Cohen-Wolkowiez; Nicole R White; Arlene Bridges; Daniel K Benjamin; Angela D M Kashuba
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-09-22       Impact factor: 3.205

Review 10.  Innovative Study Designs Optimizing Clinical Pharmacology Research in Infants and Children.

Authors:  Stephen J Balevic; Michael Cohen-Wolkowiez
Journal:  J Clin Pharmacol       Date:  2018-10       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.